Clinical Evidence
254 results
HDx therapy enabled by Theranova
A randomized prospective cross over study on the effects of medium cut-off membranes on T cellular and serologic immune phenotypes in hemodialysis
HDx therapy enabled by Theranova
A Randomized, Open-Label, Crossover Clinical Study to Compare the Effect of Hemodialysis Performed With a Medium Cut-Off Membrane vs. That With a High-Flux Membrane on Endothelial Function
HDx therapy enabled by Theranova
A trial Evaluating Mid Cut-Off Value Membrane Clearance of Albumin and Light Chains in Hemodialysis Patients: A Safety Device Study
HD
Acetate-free, citrate-acidified bicarbonate dialysis improves serum calcification propensity-a preliminary study. Lorenz G, et al.
HD
Acute effect of citrate bath on postdialysis alkalaemia - De Sequera Ortiz P, et al.
HDx therapy enabled by Theranova
An initial evaluation of expanded hemodialysis on hospitalizations, drug utilization, costs, and patient utility in Colombia.
HDx therapy enabled by Theranova
Are medium cut-off membranes the future, or the promising reality for chronic hemodialysis patients?
HDx therapy enabled by Theranova
Arteriovenous fistula as the vascular access contributes to better survival of hemodialysis patients with COVID-19 infection
HDx therapy enabled by Theranova
Assessment of safety and efficacy of expanded hemodialysis using medium cutoff dialyzer in comparison to hemodiafiltration.
PD
Assessment of the association between increasing membrane pore size and endotoxin permeability using a novel experimental dialysis simulation set-up
PD
Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels - Jones S, et al.
HD
Biofeedback dialysis for hypotension and hypervolemia: a systematic review and meta-analysis - Nesrallah et al.
Vantive is a trademark of Vantive Health LLC or its affiliates.